Yingjie Qiu
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 23, 2026
A Biomarker-Based Dose-Schedule Optimization Design for Immunotherapy Trials.Yingjie Qiu, Yan Han, Beibei Guo
|Sep 27, 2025
A randomized Bayesian phase I-II dose optimization design for combination cancer therapies with progression-free survival end point.Yingjie Qiu, Mingyue Li
|Sep 05, 2025
A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials.Yingjie Qiu, Mingyue Li
|May 15, 2025
A model-free phase I/II dose optimization design for immunotherapy trials.Yingjie Qiu, Mengyi Lu, Yan Han
|Nov 11, 2024
A Bayesian Dynamic Model-Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials.Yingjie Qiu, Mingyue Li
|Jan 11, 2024
Adaptive phase I-II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies.Yong Zang, Beibei Guo, Yingjie Qiu
Pageof 1
